MKMK International Medical

Medical team

Specialist in stem cell and immune cell therapies

DoctorCell Processing Facility
Dr. Hiroshi Terunuma

Director of N2 Clinic Yotsuya

Dr. Hiroshi Terunuma

Dr. Hiroshi Teranuma, Director, has been a pioneer in the field of cell culture in Japan since 2004, and has focused on research and development of immune cell therapy, stem cell therapy, and stem cell supernatant StemSup®.

With many years of experience in treating patients using cellular regenerative medicine, some of Dr. Terunuma's research results and treatment effects have been published in more than 100 scientific papers, making significant contributions to the field of regenerative medicine.

Career highlights

1985 Graduated from Tohoku University, Faculty of Medicine

1989 Completed Doctoral Program, Graduate School of Medicine, Tohoku University

1989 Assistant Professor, Northeastern University School of Medicine

1990 Visiting Fellow, Wistar Institute, USA

1992 Research Assistant Professor, University of Miami School of Medicine, USA

1993 Assistant Professor, Northeastern University School of Medicine

1995 Specialist, Japan International Cooperation Organization

1997 Lecturer, Yamanashi Medical University

2004 Founded the Biotherapy Institute of Japan (BIJ) and became its director

2007 Director, Department of Immunotherapy and Hyperthermia, Tokyo Clinic

2007 Director, Department of Immunotherapy and Hyperthermia, Southern Tohoku Medical Clinic

2021 Director of N2 Clinic Yotsuya

Biotherapy Institute of Japan, Inc.(BIJ)

High-quality cell culture processing facility with 20 years of experience

In order to provide highly safe and high quality regenerative medicine to all clients, specialized cell culture techniques, equipment, facilities and extensive experience are essential.

Our partner organization, Biotherapy Institute of Japan, Inc.(BIJ), was established in 2004 and has more than 20 years of experience in cell cultivation. It has been certified as a cell culture processing facility by the Pharmaceutical and Medical Device Agency (PMDA), an independent administrative body commissioned by the Ministry of Health, Labour and Welfare. Moreover, it has many patents and achievements in the field of cell culture and is a world leader in culture technology.

In order for all clients to receive the highest quality regenerative medicine, all cells and preparations cultured and prepared at the Institute are subject to thorough quality control and safety testing.

Approved facility numbers

株式会社日本バイオセラピー研究所 豊洲本社CPF: FA3150009

株式会社日本バイオセラピー研究所 筑波研究所CPF: FA3200003

Biotherapy Institute of Japan

Contact us

Message on WeChatMessage on WhatsAppSend an email